10-Q Filing

TRANSMEDICS GROUP, INC. CIK: 1756262 Q1 2022

Filing Information

Form Type	10-Q
Accession Number	`0001564590-22-018257`
Period End Date	20220331
Filing Date	20220505
Fiscal Year	2022
Fiscal Period	Q1
XBRL Instance	tmdx-10q_20220331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 67 Income Statement 35 Cash Flow Statement 67 Stockholders Equity 21 Comprehensive Income 13

Balance Sheet 67 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, No Par Value	`PreferredStockNoParValue`	-	USD	Point-in-time
Preferred Stock, No Par Value	`PreferredStockNoParValue`	-	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$25.58M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$26.73M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$17.90M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$66.87M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$54.10M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, No Par Value	`CommonStockNoParValue`	-	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$5.93M	USD	Point-in-time
Common Stock, No Par Value	`CommonStockNoParValue`	-	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$11.72M	USD	Point-in-time
Inventory	`InventoryNet`	$16.71M	USD	Point-in-time
Inventory	`InventoryNet`	$14.86M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	27.97M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.46M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.36M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	27.79M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$105.80M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$118.70M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	27.79M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	27.97M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$9.84M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.04M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$500.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$500.00K	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$5.67M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$5.85M	USD	Point-in-time
Total assets	`Assets`	$134.89M	USD	Point-in-time
Total assets	`Assets`	$124.01M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.65M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.93M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$16.34M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$15.74M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$247.00K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$250.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.34M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$20.26M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$23.24M	USD	Point-in-time
Long-term debt, net of discount and current portion	`LongTermDebtNoncurrent`	$35.33M	USD	Point-in-time
Long-term debt, net of discount and current portion	`LongTermDebtNoncurrent`	$35.20M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$8.60M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$8.51M	USD	Point-in-time
Total liabilities	`Liabilities`	$64.10M	USD	Point-in-time
Total liabilities	`Liabilities`	$67.04M	USD	Point-in-time
Commitments and contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, no par value; 25,000,000 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, no par value; 25,000,000 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, no par value; 150,000,000 shares authorized; 27,968,583 shares and 27,791,615 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively	`CommonStockValue`	$510.49M	USD	Point-in-time
Common stock, no par value; 150,000,000 shares authorized; 27,968,583 shares and 27,791,615 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively	`CommonStockValue`	$513.20M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-285.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-188.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-453.01M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-442.45M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$59.91M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$67.85M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$103.89M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$97.67M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$124.01M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$134.89M	USD	Point-in-time

Income Statement 35 line items

Line Item	Tag	Value	Unit	Period
Net revenue	`Revenues`	$7.05M	USD	1 Quarter
Net revenue	`Revenues`	$15.88M	USD	1 Quarter
Cost of revenue	`CostOfRevenue`	$3.78M	USD	1 Quarter
Cost of revenue	`CostOfRevenue`	$2.24M	USD	1 Quarter
Gross profit	`GrossProfit`	$12.10M	USD	1 Quarter
Gross profit	`GrossProfit`	$4.81M	USD	1 Quarter
Research, development and clinical trials	`ResearchAndDevelopmentExpense`	$4.53M	USD	1 Quarter
Research, development and clinical trials	`ResearchAndDevelopmentExpense`	$7.53M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$13.94M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$6.79M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$11.32M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$21.47M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-6.51M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-9.37M	USD	1 Quarter
Interest expense	`InterestExpense`	$952.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$960.00K	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-454.00K	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-227.00K	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-1.41M	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-1.19M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-10.56M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-7.91M	USD	1 Quarter
Provision for income taxes	`CurrentIncomeTaxExpenseBenefit`	$6.00K	USD	1 Quarter
Provision for income taxes	`CurrentIncomeTaxExpenseBenefit`	$4.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-10.56M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-44.20M	USD	Annual
Net loss	`NetIncomeLoss`	$-7.92M	USD	1 Quarter
Net loss per share attributable to common stockholders, basic	`EarningsPerShareBasic`	$-0.29	USD	1 Quarter
Net loss per share attributable to common stockholders, basic	`EarningsPerShareBasic`	$-0.38	USD	1 Quarter
Net loss per share attributable to common stockholders, diluted	`EarningsPerShareDiluted`	$-0.29	USD	1 Quarter
Net loss per share attributable to common stockholders, diluted	`EarningsPerShareDiluted`	$-0.38	USD	1 Quarter
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	27.37M	shares	1 Quarter
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	27.95M	shares	1 Quarter
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	27.95M	shares	1 Quarter
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	27.37M	shares	1 Quarter

Cash Flow Statement 67 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-10.56M	USD	1 Quarter
Net loss	`ProfitLoss`	$-7.92M	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$507.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$445.00K	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$1.11M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$2.31M	USD	1 Quarter
Non-cash interest expense and end of term accretion expense	`NonCashInterestAndEndOfTermAccretionExpense`	$130.00K	USD	1 Quarter
Non-cash interest expense and end of term accretion expense	`NonCashInterestAndEndOfTermAccretionExpense`	$137.00K	USD	1 Quarter
Non-cash lease expense	`NonCashLeaseExpense`	$178.00K	USD	1 Quarter
Net amortization of premiums on marketable securities	`AmortizationOfDebtDiscountPremium`	$228.00K	USD	1 Quarter
Net amortization of premiums on marketable securities	`AmortizationOfDebtDiscountPremium`	$391.00K	USD	1 Quarter
Unrealized foreign currency transaction losses	`ForeignCurrencyTransactionGainLossUnrealized`	$-484.00K	USD	1 Quarter
Unrealized foreign currency transaction losses	`ForeignCurrencyTransactionGainLossUnrealized`	$-214.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$5.80M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$583.00K	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$2.93M	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$381.00K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$908.00K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-88.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-4.01M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-82.00K	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-4.00K	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-180.00K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$182.00K	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$1.24M	USD	1 Quarter
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$23.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-18.41M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.33M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$20.00K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.95M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$2.03M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$11.71M	USD	1 Quarter
Proceeds from sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$21.00M	USD	1 Quarter
Proceeds from sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$14.50M	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$10.51M	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$9.27M	USD	1 Quarter
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$202.00K	USD	1 Quarter
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$372.00K	USD	1 Quarter
Proceeds from issuance of common stock in connection with employee stock purchase plan	`ProceedsFromStockPlans`	$203.00K	USD	1 Quarter
Proceeds from issuance of common stock in connection with employee stock purchase plan	`ProceedsFromStockPlans`	$211.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$583.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$405.00K	USD	1 Quarter
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-196.00K	USD	1 Quarter
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-379.00K	USD	1 Quarter
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$2.15M	USD	1 Quarter
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-7.68M	USD	1 Quarter
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$18.40M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.08M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$26.08M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$27.23M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$18.40M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.08M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$26.08M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$27.23M	USD	Point-in-time
Transfers of inventory to property and equipment	`InventoryTransferToPropertyPlantAndEquipment`	$1.03M	USD	1 Quarter
Transfers of inventory to property and equipment	`InventoryTransferToPropertyPlantAndEquipment`	$429.00K	USD	1 Quarter
Purchases of property and equipment included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$7.00K	USD	1 Quarter
Purchases of property and equipment included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$939.00K	USD	1 Quarter
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$25.58M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$26.73M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$17.90M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$500.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$500.00K	USD	Point-in-time
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$18.40M	USD	Point-in-time
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.08M	USD	Point-in-time
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$26.08M	USD	Point-in-time
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$27.23M	USD	Point-in-time

Stockholders Equity 21 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$59.91M	USD	Point-in-time
Balance	`StockholdersEquity`	$67.85M	USD	Point-in-time
Balance	`StockholdersEquity`	$103.89M	USD	Point-in-time
Balance	`StockholdersEquity`	$97.67M	USD	Point-in-time
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$202.00K	USD	1 Quarter
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$372.00K	USD	1 Quarter
Issuance of common stock in connection with employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$211.00K	USD	1 Quarter
Issuance of common stock in connection with employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$203.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$1.11M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$2.31M	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-24.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-2.00K	USD	1 Quarter
Unrealized gains (losses) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$8.00K	USD	1 Quarter
Unrealized gains (losses) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-73.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-10.56M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-44.20M	USD	Annual
Net loss	`NetIncomeLoss`	$-7.92M	USD	1 Quarter
Balance	`StockholdersEquity`	$59.91M	USD	Point-in-time
Balance	`StockholdersEquity`	$67.85M	USD	Point-in-time
Balance	`StockholdersEquity`	$103.89M	USD	Point-in-time
Balance	`StockholdersEquity`	$97.67M	USD	Point-in-time

Comprehensive Income 13 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-10.56M	USD	1 Quarter
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, Tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	-	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-44.20M	USD	Annual
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, Tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	-	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.92M	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-24.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-2.00K	USD	1 Quarter
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$8.00K	USD	1 Quarter
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-73.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$6.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-97.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-7.91M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-10.66M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.